华夏时报记者张斯文于娜北京报道 被资本市场称为“疫苗行业世纪对决”的博弈,在7月9日加勒比海岛国安提瓜和巴布达的特别股东大会上达到高潮。 7月7日,6年前购入科兴生物(NASDAQ: SVA)股票的股东收到了一张每股55美元的股息支票——这笔钱相当于他当初买入股价(6.47美元)的8.5倍。然而,如此“慷慨”的分红却被中小股东视为内斗副产品。 一边是现任董事会以“75亿美元”分红为筹码争夺...
Source Link华夏时报记者张斯文于娜北京报道 被资本市场称为“疫苗行业世纪对决”的博弈,在7月9日加勒比海岛国安提瓜和巴布达的特别股东大会上达到高潮。 7月7日,6年前购入科兴生物(NASDAQ: SVA)股票的股东收到了一张每股55美元的股息支票——这笔钱相当于他当初买入股价(6.47美元)的8.5倍。然而,如此“慷慨”的分红却被中小股东视为内斗副产品。 一边是现任董事会以“75亿美元”分红为筹码争夺...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.